a:5:{s:8:"template";s:9184:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8"/>
<meta content="text/html; charset=utf-8" http-equiv="content-type"/>
<meta content="IE=edge" http-equiv="X-UA-Compatible"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<title>{{ keyword }}</title>
<link href="https://fonts.googleapis.com/css?family=Roboto+Condensed%3A300%2C300i%2C400%2C400i%2C600%2C600i%2C800%2C800i&amp;subset=latin%2Clatin-ext" id="bulk-fonts-css" media="all" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css">@supports ((position:-webkit-sticky) or (position:sticky)){}@supports ((position:-webkit-sticky) or (position:sticky)){}@supports ((position:-webkit-sticky) or (position:sticky)){}p.has-drop-cap:not(:focus)::first-letter{float:left;font-size:8.4em;line-height:.68;font-weight:100;margin:.05em .1em 0 0;text-transform:uppercase;font-style:normal}p.has-drop-cap:not(:focus)::after{content:"";display:table;clear:both;padding-top:14px} @font-face{font-family:'Roboto Condensed';font-style:italic;font-weight:300;src:local('Roboto Condensed Light Italic'),local('RobotoCondensed-LightItalic'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVg2ZhZI2eCN5jzbjEETS9weq8-19eDpCEoY9Nc.ttf) format('truetype')}@font-face{font-family:'Roboto Condensed';font-style:italic;font-weight:400;src:local('Roboto Condensed Italic'),local('RobotoCondensed-Italic'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVj2ZhZI2eCN5jzbjEETS9weq8-19eLAQM4.ttf) format('truetype')}@font-face{font-family:'Roboto Condensed';font-style:normal;font-weight:300;src:local('Roboto Condensed Light'),local('RobotoCondensed-Light'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVi2ZhZI2eCN5jzbjEETS9weq8-33mZGCoYag.ttf) format('truetype')}@font-face{font-family:'Roboto Condensed';font-style:normal;font-weight:400;src:local('Roboto Condensed'),local('RobotoCondensed-Regular'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVl2ZhZI2eCN5jzbjEETS9weq8-19y7CA.ttf) format('truetype')} /*! normalize.css v3.0.3 | MIT License | github.com/necolas/normalize.css */html{font-family:sans-serif;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0}footer,nav{display:block}a{background-color:transparent}a:active,a:hover{outline:0}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:10px;-webkit-tap-highlight-color:transparent}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#333;background-color:#fff}a{color:#337ab7;text-decoration:none}a:focus,a:hover{color:#23527c;text-decoration:underline}a:focus{outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}p{margin:0 0 10px}.text-center{text-align:center}ul{margin-top:0;margin-bottom:10px}.container{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}.row{margin-left:-15px;margin-right:-15px}.dropdown{position:relative}.dropdown-toggle:focus{outline:0}.nav{margin-bottom:0;padding-left:0;list-style:none}.nav>li{position:relative;display:block}.nav>li>a{position:relative;display:block;padding:10px 15px}.nav>li>a:focus,.nav>li>a:hover{text-decoration:none;background-color:#eee}.navbar{position:relative;min-height:50px;margin-bottom:20px;border:1px solid transparent}@media (min-width:768px){.navbar{border-radius:4px}}@media (min-width:768px){.navbar-header{float:left}}.container>.navbar-header{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.container>.navbar-header{margin-right:0;margin-left:0}}.navbar-fixed-top{position:fixed;right:0;left:0;z-index:1030}@media (min-width:768px){.navbar-fixed-top{border-radius:0}}.navbar-fixed-top{top:0;border-width:0 0 1px}.navbar-brand{float:left;padding:15px 15px;font-size:18px;line-height:20px;height:50px}.navbar-brand:focus,.navbar-brand:hover{text-decoration:none}@media (min-width:768px){.navbar>.container .navbar-brand{margin-left:-15px}}.navbar-nav{margin:7.5px -15px}.navbar-nav>li>a{padding-top:10px;padding-bottom:10px;line-height:20px}@media (min-width:768px){.navbar-nav{float:left;margin:0}.navbar-nav>li{float:left}.navbar-nav>li>a{padding-top:15px;padding-bottom:15px}}@media (min-width:768px){.navbar-right{float:right!important;margin-right:-15px}}.navbar-default{background-color:#f8f8f8;border-color:#e7e7e7}.navbar-default .navbar-brand{color:#777}.navbar-default .navbar-brand:focus,.navbar-default .navbar-brand:hover{color:#5e5e5e;background-color:transparent}.navbar-default .navbar-nav>li>a{color:#777}.navbar-default .navbar-nav>li>a:focus,.navbar-default .navbar-nav>li>a:hover{color:#333;background-color:transparent}.container-fluid:after,.container-fluid:before,.container:after,.container:before,.nav:after,.nav:before,.navbar-header:after,.navbar-header:before,.navbar:after,.navbar:before,.row:after,.row:before{content:" ";display:table}.container-fluid:after,.container:after,.nav:after,.navbar-header:after,.navbar:after,.row:after{clear:both}@-ms-viewport{width:device-width}body,html{overflow-x:hidden}body{font-family:'Roboto Condensed',"Helvetica Neue",helvetica,arial,sans-serif;padding:0;color:#404040;font-weight:400;line-height:1.8;font-size:16px;word-wrap:break-word;overflow-x:hidden}a,a:active,a:focus,a:hover{text-decoration:none;color:#0090ff}ul{padding-left:20px}a:active{border-bottom:none}.page-area{padding-top:70px}@media (min-width:768px){.navbar-nav>li>a{padding-top:25px;padding-bottom:25px;transition:all .5s ease-in-out;-moz-transition:all .5s ease-in-out;-webkit-transition:all .5s ease-in-out;-o-transition:all .5s ease-in-out}#site-navigation .container{padding-left:0;padding-right:0}}@media (max-width:767px){.navbar-nav a:focus,.navbar-nav a:hover{color:#fff!important;background-color:#000!important}.menu-container{width:70%;position:absolute;left:0;height:100vh;transform:translate3d(-100%,0,0);overflow-y:auto;overflow-x:auto;background-color:#fff;top:100%}.navbar-brand{padding-right:55px!important}.page-area{left:0;transform:translate3d(0,0,0);transition:transform .5s ease}.navbar-nav{padding:0;margin:0}.navbar-nav a{font-size:14px;padding:12px 10px!important;margin:0!important;line-height:16px!important;float:left!important;margin:0!important;width:100%;text-transform:none!important;word-wrap:break-word;white-space:normal!important}.navbar-nav li{padding:0!important;margin:0!important}}#site-navigation{min-height:70px}.navbar-nav>li>a{border-bottom:0;text-transform:uppercase}.site-title{margin:0;padding:0;font-size:22px;line-height:28px}p.site-description{font-size:13px;line-height:18px;margin:0;-webkit-transition:all .5s ease;transition:all .5s ease}.site-branding-logo{float:left}.site-branding-logo a{border:none;z-index:9999;position:relative}.navbar-brand{padding:10px 15px;height:auto;z-index:99999;position:relative;z-index:1}.navbar{margin-bottom:0}.main-menu{position:relative}.navbar-fixed-top{position:absolute}#site-navigation{background-color:#fff;-webkit-box-shadow:0 10px 20px -12px rgba(0,0,0,.42),0 3px 20px 0 rgba(0,0,0,.12),0 8px 10px -5px rgba(0,0,0,.2);box-shadow:0 10px 20px -12px rgba(0,0,0,.42),0 3px 20px 0 rgba(0,0,0,.12),0 8px 10px -5px rgba(0,0,0,.2);border:none}#site-navigation,nav a{-webkit-transition:all .3s ease;transition:all .3s ease;color:#000}.footer-credits{border-top:1px solid #ccc;padding:15px;clear:both;margin-top:20px;background-color:#fff}</style>
 </head>
<body class="wp-custom-logo" id="blog">
<div class="main-menu">
<nav class="navbar navbar-default navbar-fixed-top" id="site-navigation">
<div class="container">
<div class="navbar-header">
<div class="site-header">
<div class="site-branding-logo">
<a class="custom-logo-link" href="#" itemprop="url" rel="home"></a> </div>
<div class="site-branding-text navbar-brand">
<p class="site-title"><a href="#" rel="home">{{ keyword }}</a></p>
<p class="site-description">
{{ keyword }}</p>
</div>
</div>
</div>
<div class="menu-container"><ul class="nav navbar-nav navbar-right" id="menu-menu-1"><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-72 dropdown" id="menu-item-72"><a class="dropdown-toggle" data-toggle="dropdown" href="#" title="Projects">Projects</a>
</li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-73 dropdown" id="menu-item-73"><a class="dropdown-toggle" data-toggle="dropdown" href="#" title="About">About</a>
</li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-74" id="menu-item-74"><a href="#" title="Contacts">Contacts</a></li>
</ul></div> </div>
</nav>
</div>
<div class="page-area">	
{{ text }}
<br>
<br>
{{ links }}
</div>
<footer class="footer-credits container-fluid row" id="colophon">
<div class="container">
<p class="footer-credits-text text-center">{{ keyword }} 2020</p>
</div>
</footer>
</body>
</html>";s:4:"text";s:8462:"The Company’s primary focus is products related to human health and well-being. Current and historical return on assets (ROA) values for Johnson & Johnson (JNJ) over the last 10 years. The 10km course does 2 loops of the below course. Grant Type No. We use cookies to offer you a better browsing experience. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), Johnson & Johnson. This page shows recent SEC filings related to Johnson & Johnson Your question/message has been sent to the race director. You can find instructions at https://www.whatismybrowser.com/guides/how-to-enable-cookies/auto. Grant Type No. Please check your download folder. Exhibit 10(a) Johnson & Johnson Executive Incentive Plan ~ Plan Document ~ (Amended as of November 28, 2018) I. Exhibit 10.1 June 20, 2018 Sandra Peterson One Johnson & Johnson Plaza New Brunswick, New Jersey 08933 Dear Sandi: This letter (“Agreement”) will confirm the terms of your transition and separation from employment with Johnson & Johnson (the “Company” or “Johnson & Johnson”). Your last day of employment (the “Separation Date”) will be October 1, 2018. If underlying, EX-99.1 Exhibit 99.1 News Release Media Contacts: Cristal Downing Phone: (908) 616-8833 Courtney Dugan Phone: (347) 452-1061 Investor Contacts: Chris DelOrefice Phone: (732) 524-2955 Jennifer McIntyre Phone: (732) 524-3922 Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen’s Leadership in Novel Treatments for Autoimmune Diseases $6.5 Billion Acquisition Through an All-Ca, Exhibit 99.1 JOHNSON & JOHNSON REPORTS 2020 SECOND-QUARTER RESULTS: •Sales of $18.3 billion reflecting a decline of 10.8%, operational decline of 9.0%* and adjusted operational decline of 8.8%*, primarily driven by the negative impact of the COVID-19 pandemic •EPS of $1.36 decreased 34.6%; adjusted EPS of $1.67 decreased 35.3%*; 2019 included gain from sale of Advanced Sterilization Products (ASP), Exhibit 99.2 Johnson & Johnson and Subsidiaries Supplementary Sales Data (Unaudited; Dollars in Millions) SECOND QUARTER Percent Change 2020 2019 Total Operations Currency Sales to customers by geographic area U.S. $ 9,539 10,403 (8.3) % (8.3) - Europe 4,063 4,733 (14.2) (11.5) (2.7) Western Hemisphere excluding U.S. 1,133 1,455 (22.1) (8.9) (13.2) Asia-Pacific, Africa 3,601 3,971 (9.3) (7.7) (1.6, Exhibit 99.2 Johnson & Johnson and Subsidiaries Supplementary Sales Data (Unaudited; Dollars in Millions) FIRST QUARTER Percent Change 2020 2019 Total Operations Currency Sales to customers by geographic area U.S. $ 10,699 10,129 5.6 % 5.6 — Europe 4,827 4,609 4.7 7.5 (2.8 ) Western Hemisphere excluding U.S. 1,502 1,503 (0.1 ) 8.5 (8.6 ) Asia-Pacific, Africa 3,663 3,780 (3.1 ) (1.9 ) (1.2 ) Intern, Exhibit 99.1 JOHNSON & JOHNSON REPORTS 2020 FIRST-QUARTER RESULTS: • Sales of $20.7 Billion reflecting strong growth of 3.3%, operational growth of 4.8%* and adjusted operational growth of 5.6%*, inclusive of the overall estimated negative impact of the COVID-19 pandemic • EPS of $2.17 increased 56.1%; adjusted EPS of $2.30 increased 9.5%* • Dividend increase of 6.3% announced • Long term fundamen, Exhibit 99.2 Johnson & Johnson and Subsidiaries Supplementary Sales Data (Unaudited; Dollars in Millions) FOURTH QUARTER Percent Change 2019 2018 Total Operations Currency Sales to customers by geographic area U.S. $ 10,774 10,629 1.4 % 1.4 — Europe 4,663 4,730 (1.4) 1.0 (2.4) Western Hemisphere excluding U.S. 1,495 1,456 2.6 9.3 (6.7) Asia-Pacific, Africa 3,815 3,579 6.6 5.8 0.8 International 9,9, Exhibit 99.1 JOHNSON & JOHNSON REPORTS 2019 FOURTH-QUARTER AND FULL YEAR RESULTS: • 2019 Fourth-Quarter Sales of $20.7 Billion reflecting growth of 1.7%, operational growth of 2.6%* and adjusted operational growth of 3.4%* • 2019 Full-Year Sales of $82.1 Billion reflecting growth of 0.6%, operational growth of 2.8%* and adjusted operational growth of 4.5%* • 2019 Fourth-Quarter EPS of $1.50 increa, Exhibit 99.1 Media contacts: Kellie McLaughlin Mobile: (609) 468-8356 Investor contacts: Lesley Fishman Chris DelOrefice Office: (732) 524-3922 Office: (732) 524-2955 Janssen Announces Completion of Acquisition of Investigational Bermekimab from XBiotech Inc. HORSHAM, PA - December 30, 2019 - The Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) announced today the completion of th, Exhibit 99.1 Press Contacts: Ernie Knewitz Cristal Downing (732) 524-1090 (732) 524-3283. 20 minutes to 30 minutes after the last finisher - Awards Ceremony. Exhibit 99.1 FOR IMMEDIATE RELEASE Global Media Relations: Ernie Knewitz (732) 524-6623 Investor Relations: Matt Stuckley (732) 524-2617 Christopher DelOrefice (732) 524-2955 Johnson & Johnson Announces Completion of Acquisition of Auris Health, Inc. Auris will Enable Johnson & Johnson to Deliver on the Promise of Digital Surgery and Drive Better Outcomes for Patients NEW BRUNSWICK, NJ - April 1, Exhibit 99.15 ` Johnson & Johnson Reports 2018 Fourth-Quarter Results: 2018 Fourth-Quarter Sales of $20.4 Billion increased 1.0%; EPS was $1.12 2018 Full-Year Sales of $81.6 Billion increased 6.7%, Full-Year EPS was $5.61 Adjusted 2018 Fourth-Quarter EPS was $1.97, an increase of 13.2%*, and Adjusted 2018 Full-Year EPS was $8.18, an increase of 12.1%* Strong 2018 Full-Year Operational Sales and Ad, Exhibit 99.2O Johnson & Johnson and Subsidiaries Condensed Consolidated Statement of Earnings (Unaudited; in Millions Except Per Share Figures) FOURTH QUARTER 2018 2017* Percent Percent Percent Increase Amount to Sales Amount to Sales (Decrease) Sales to customers $ 20,394 100.0 $ 20,195 100.0 1.0 Cost of products sold 6,961 34.1 7,259 36.0 (4.1) Gross Profit 13,433 65.9 12,936 64.0 3.8 Selling, m, Exhibit 99.1 FOR IMMEDIATE RELEASE Media Contacts: Ernie Knewitz Donna Lorenson (732) 524-6623 (410) 258-8571 (917) 697-2318 (M), Exhibit 99.1 FOR IMMEDIATE RELEASE Media Contacts: Ernie Knewitz Cristal Downing (732) 524-6623 (732) 524-3283 (917) 697-2318 (M) (908) 616-8833 Investor Contacts: Christopher DelOrefice Lesley Fishman (732) 524-2955 (732) 524-3922 Johnson & Johnson Announces $5 Billion Share Repurchase Program New Brunswick, NJ (December 17, 2018) - Johnson & Johnson (NYSE: JNJ) today announced that its Board of, Exhibit 99.2O Johnson & Johnson and Subsidiaries Condensed Consolidated Statement of Earnings (Unaudited; in Millions Except Per Share Figures) THIRD QUARTER 2018 2017* Percent Percent Percent Increase Amount to Sales Amount to Sales (Decrease) Sales to customers $ 20,348 100.0 $ 19,650 100.0 3.6 Cost of products sold 6,589 32.4 6,925 35.2 (4.9) Gross Profit 13,759 67.6 12,725 64.8 8.1 Selling, ma, Exhibit 99.15 Johnson & Johnson Reports 2018 Third-Quarter Results: 2018 Third-Quarter Sales of $20.3 Billion Increased 3.6% versus 2017 2018 Third-Quarter EPS was $1.44 2018 Adjusted Third-Quarter EPS of $2.05 increased 7.9%* Strong Operational Sales and Adjusted EPS Growth* Company Increased Sales and EPS Guidance New Brunswick, N.J. (October 16, 2018) - Johnson & Johnson (NYSE: JNJ) today annou, Exhibit 99.1 FOR IMMEDIATE RELEASE Media Contacts: Natalia Salomao Donna Lorenson (732) 325-8306 (410) 258-8571, Exhibit 99.15 Johnson & Johnson Reports 2018 Second-Quarter Results: 2018 Second-Quarter Sales of $20.8 Billion Increased 10.6% versus 2017 2018 Second-Quarter EPS was $1.45 2018 Adjusted Second-Quarter EPS of $2.10 increased 14.8%* Accelerating Operational Sales Growth in the Second Quarter New Brunswick, N.J. (July 17, 2018) - Johnson & Johnson (NYSE: JNJ) today announced sales of $20.8 billion, Exhibit 99.2O Johnson & Johnson and Subsidiaries Condensed Consolidated Statement of Earnings (Unaudited; in Millions Except Per Share Figures) SECOND QUARTER 2018 2017* Percent Percent Percent Increase Amount to Sales Amount to Sales (Decrease) Sales to customers $ 20,830 100.0 $ 18,839 100.0 10.6 Cost of products sold 6,927 33.3 5,846 31.0 18.5 Gross Profit 13,903 66.7 12,993 69.0 7.0 Selling, m, Exhibit 99.2 FOR IMMEDIATE RELEASE Press Contacts: Ernie Knewitz (732) 524-6623 (917) 697-2318 (M) Investor Contacts: Joseph J. Wolk Lesley Fishman (732) 524-1142 (732) 524-3922 Johnson & Johnson Appoints Senior Leaders to Executive Committee NEW BRUNSWICK, N.J., June 22, 2018 - Johnson & Johnson today announced the appointment of a number of senior leaders to the Company’s Executive Committee. ";s:7:"keyword";s:23:"johnson and johnson 10k";s:5:"links";s:1627:"<a href="http://newdestinychurchpc.com/blog/article.php?tag=Arroyo-Grande-Jane-Doe-6bb478">Arroyo Grande Jane Doe</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=pull-apart-garlic-bread-recipe-from-scratch-6bb478">Pull Apart Garlic Bread Recipe From Scratch</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=curtin-careers-resume-6bb478">Curtin Careers Resume</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=brandi-glanville-denise-6bb478">Brandi Glanville Denise</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=American-Renal-Associates-6bb478">American Renal Associates</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=couldn%27t-get-it-right-chords-6bb478">Couldn't Get It Right Chords</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=Neymar-to-Chelsea-6bb478">Neymar To Chelsea</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=rodeo-travis-scott-vinyl-6bb478">Rodeo Travis Scott Vinyl</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=the-day-the-violence-died-full-episode-6bb478">The Day The Violence Died Full Episode</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=danny-welbeck-fifa-17-6bb478">Danny Welbeck Fifa 17</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=razer-phone-2-price-6bb478">Razer Phone 2 Price</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=ireland-population-2020-6bb478">Ireland Population 2020</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=paul-hudson-wikipedia-6bb478">Paul Hudson Wikipedia</a>,
";s:7:"expired";i:-1;}